| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.7 |